Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 07 Mar 2023
People who have had a normal gastrointestinal (GI) biopsy are still at risk of developing inflammatory bowel disease (IBD) over the years...
Read Full NewsParticipation in accountable care organizations shows better diabetes care outcomes for patients in rural areas than for those in urban settings.
In patients with classical 21-hydroxylase deficiency, growth-promoting therapies have variable effects: They increase final height relative to midparental height in boys but not in girls.
Higher relative fat mass is associated with increased odds of having chronic diarrhea, although the measure alone shows limited ability to predict risk.
Risk rises with all three types of diabetes mellitus but mostly with type 2.
As GLP-1 use rise, constipation remains a leading cause of discontinuation. Experts offer practical strategies for prevention and management.
In patients with type 2 diabetes, 12 months of dapagliflozin therapy is significantly associated with reduced liver fat, independent of weight loss or other metabolic benefits.
Physicians must deploy specific tools in specific ways at specific times — adding to the time-consuming treatment costs.
1.
Words matter to people living with cancer. Here's how verbal microaggressions affect their mental state
2.
High Rate of Deep Remission for Relapsed/Refractory CLL Using Triple Regimen.
3.
Radioiodine therapy found to improve relative survival rates of differentiated thyroid cancer patients
4.
Sickle Cell Disease Drug Pulled From Global Markets
5.
Nasal therapeutic HPV vaccine could prevent cervical cancer
1.
Unveiling the Chadwick Sign: A Revolutionary New Tool for Detecting Early Signs of Cancer
2.
Understanding the Rare Disease: Werner Syndrome Explained
3.
Unveiling the Mystery Behind Castleman Disease – Understanding Its Causes and Symptoms
4.
Exploring The Science Of Hematopoietic Stem Cell Transplantation: What You Need To Know
5.
Understanding Lymphedema: Symptoms, Causes, and Treatment
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
3.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Conclusion
4.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
5.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge